Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy

ConclusionBrolucizumab-associated IOI, including retinal vasculitis and retinal occlusion, is a rare but important adverse event that can cause severe vision loss. Prompt diagnosis with FA and treatment with systemic or local steroids should be considered.

Source: Japanese Journal of Ophthalmology - February 5, 2021 Category: Opthalmology Source Type: research